Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.

Oncology reports - 1 Oct 2011

Cai Yi-Ran, Zhang Hai-Qing, Qu Yang, Mu Jing, Zhao Dan, Zhou Li-Juan, Yan Hong, Ye Jian-Wei, Liu Yan

Abstract excerpt

Non-small cell lung carcinoma (NSCLC) is a leading cause of cancer-related deaths. Aberrance of the two oncogenes MET and SOX2 are frequently encountered in NSCLC. Exons 18 through 21 of the EGFR gene were screened and MET and SOX2 immunostaining was conducted to analyze the immunohistological staining of MET and SOX2 and the EGFR mutation status. One hundred and fifty tissue samples were examined including 57...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to SOX2 gene

Share to Lung Neoplasms

Share to Mutation

Share to Proto-Oncogene Proteins c-met

Share to SOXB1 Transcription Factors

Source

Identifiers

PMID: 21687954
DOI: 10.3892/or.2011.1349

Genes

MET
SOX2
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.PMID 21687954Read ↗

The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.Semantic proximity Read ↗

Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung CancerSemantic proximity Read ↗

Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and TumorigenicitySemantic proximity Read ↗

Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer.Semantic proximity Read ↗

Analysis of SOX gene family expression and prognostic significance in lung adenocarcinoma based on tumor databasesSemantic proximity Read ↗

Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.Semantic proximity Read ↗

SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines.Semantic proximity Read ↗

MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation.Semantic proximity Read ↗

SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer CellsSemantic proximity Read ↗

The Emerging Role of SOX2 in Cell Proliferation and Survival and Its Crosstalk with Oncogenic Signaling in Lung CancerSemantic proximity Read ↗

Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.Semantic proximity Read ↗

Evidence That SOX2 Overexpression Is Oncogenic in the LungSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.